MX9205775A - Pirrolidinas substituidas, procedimiento para su fabricacion y medicamento que las contiene - Google Patents
Pirrolidinas substituidas, procedimiento para su fabricacion y medicamento que las contieneInfo
- Publication number
- MX9205775A MX9205775A MX9205775A MX9205775A MX9205775A MX 9205775 A MX9205775 A MX 9205775A MX 9205775 A MX9205775 A MX 9205775A MX 9205775 A MX9205775 A MX 9205775A MX 9205775 A MX9205775 A MX 9205775A
- Authority
- MX
- Mexico
- Prior art keywords
- procedure
- manufacture
- medicinal product
- containing medicinal
- substituted pyrrolidines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4134756A DE4134756A1 (de) | 1991-10-22 | 1991-10-22 | Verwendung von teilweise bekannten substituierten pyrrolidinen als arzneimittel, neue wirkstoffe und verfahren zu ihrer herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9205775A true MX9205775A (es) | 1993-04-01 |
Family
ID=6443116
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9205775A MX9205775A (es) | 1991-10-22 | 1992-10-08 | Pirrolidinas substituidas, procedimiento para su fabricacion y medicamento que las contiene |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0538692A1 (es) |
JP (1) | JPH05194380A (es) |
KR (1) | KR930007900A (es) |
AU (1) | AU2626392A (es) |
CA (1) | CA2080867A1 (es) |
CZ (1) | CZ311392A3 (es) |
DE (1) | DE4134756A1 (es) |
FI (1) | FI924748A (es) |
HU (1) | HUT68070A (es) |
IL (1) | IL103498A0 (es) |
MX (1) | MX9205775A (es) |
SK (1) | SK311392A3 (es) |
ZA (1) | ZA928127B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995007022A1 (en) * | 1993-09-07 | 1995-03-16 | Zeneca Limited | Fungicides |
US5473077A (en) * | 1994-11-14 | 1995-12-05 | Eli Lilly And Company | Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor agonists |
US20020037997A1 (en) | 1997-03-04 | 2002-03-28 | Gellman Samuel H. | Beta-amino acids |
NZ528663A (en) * | 2003-10-03 | 2005-08-26 | Ind Res Ltd | Method for preparing 4-hydroxymethylpyrrolidin-3-ol compounds |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05508147A (ja) * | 1989-10-25 | 1993-11-18 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | L―グルタミン酸の輸送を阻害する方法 |
-
1991
- 1991-10-22 DE DE4134756A patent/DE4134756A1/de not_active Withdrawn
-
1992
- 1992-10-07 AU AU26263/92A patent/AU2626392A/en not_active Abandoned
- 1992-10-08 MX MX9205775A patent/MX9205775A/es unknown
- 1992-10-09 EP EP92117263A patent/EP0538692A1/de not_active Withdrawn
- 1992-10-13 SK SK3113-92A patent/SK311392A3/sk unknown
- 1992-10-13 CZ CS923113A patent/CZ311392A3/cs unknown
- 1992-10-15 JP JP4301575A patent/JPH05194380A/ja active Pending
- 1992-10-19 CA CA002080867A patent/CA2080867A1/en not_active Abandoned
- 1992-10-20 ZA ZA928127A patent/ZA928127B/xx unknown
- 1992-10-20 FI FI924748A patent/FI924748A/fi unknown
- 1992-10-21 HU HU9203312A patent/HUT68070A/hu unknown
- 1992-10-21 KR KR1019920019330A patent/KR930007900A/ko not_active Application Discontinuation
- 1992-10-21 IL IL103498A patent/IL103498A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
DE4134756A1 (de) | 1993-04-29 |
HU9203312D0 (en) | 1992-12-28 |
IL103498A0 (en) | 1993-03-15 |
ZA928127B (en) | 1993-05-07 |
FI924748A (fi) | 1993-04-23 |
HUT68070A (en) | 1995-05-29 |
AU2626392A (en) | 1993-04-29 |
KR930007900A (ko) | 1993-05-20 |
CZ311392A3 (en) | 1993-09-15 |
JPH05194380A (ja) | 1993-08-03 |
CA2080867A1 (en) | 1993-04-23 |
SK311392A3 (en) | 1995-10-11 |
EP0538692A1 (de) | 1993-04-28 |
FI924748A0 (fi) | 1992-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9205908A (es) | Derivados heterobiarilicos, medicamentos que contienen estos compuestos y procedimientos para su preparacion | |
MX9206306A (es) | Peptidos, procedimiento para su produccion y composicion farmaceutica que los contiene. | |
NO924768D0 (no) | Farmasoeytisk preparat og fremgangsmaate for dets fremstilling | |
MX9202106A (es) | Composiciones antitranspirantes de barra de gel que contienen derivado de 2-oxazol idinona y procedimiento para hacerlas. | |
NO931326D0 (no) | Komposittprodukt og fremgangsmaate til fremstilling derav | |
FI954402A (fi) | Uusi farmaseuttinen tuote | |
MX9202546A (es) | Dimeros de rapamicina y composicion farmaceutica que los contiene. | |
MX9200374A (es) | Nuevos esteres esteroides, procedimiento para su preparacion y preparacion farmaceutica que los contiene. | |
DK81690D0 (da) | Pektinprodukt og fremgangsmaade til fremstilling deraf | |
MX9203394A (es) | Benzazepinas substituidas, su preparacion y composiciones farmaceuticas que contienen las mismas. | |
MX12478A (es) | Benzamidas n-sustituidas, procedimiento para su preparacion y composicion farmaceutica que las incluye | |
MX9202982A (es) | Derivados de los acidos quinolon - y naftiridon - carboxilicos, procedimiento para su obtencion y medicamentos que los contienen. | |
MX9102580A (es) | Nuevas benzodiacepinonas, procedimiento para su preparacion y composicion farmaceutica que las contiene. | |
MX9201295A (es) | Derivados de benzofurano, proceso para su preparacion y composicion farmaceutica que los contienen. | |
MX9201847A (es) | Derivados heterociclicos de antiserotoninas, procedimiento para su preparacion y medicamentos que los contienen. | |
BR9206950A (pt) | Composição farmacêutica e processo para sua preparação | |
MX9201848A (es) | Antiserotoninas, procedimiento para su preparacion y medicamentos que las contienen. | |
DK86492D0 (da) | Laegemiddel | |
MX9205775A (es) | Pirrolidinas substituidas, procedimiento para su fabricacion y medicamento que las contiene | |
MX9204239A (es) | Quinolin-2-il-metoxibencilhindroxiureas, procedimiento para su preparacion y medicamentos que las contienen. | |
MX9206612A (es) | Amidas del acido quinolilmetoxifenilacetico, procedimiento para su fabricacion y medicamento que las contiene | |
BR9205493A (pt) | Composicao farmaceutica e processo para fabricacao de composicao farmaceutica | |
MX9101594A (es) | Compuestos de indenoidol,procedimiento para su preparacion y composicion farmaceutica que los contiene | |
MX9200214A (es) | Producto farmaceutico que comprende granisetron y dexametasona. | |
MX9206820A (es) | Enzoquinoxalinas, procedimiento para su produccion y composicion farmaceutica que las contiene. |